Attached files

file filename
EX-2.1 - EXHIBIT 2.1 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC.crl12262015-ex21.htm
EX-10.4 - EXHIBIT 10.4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC.crl12262015-ex104.htm
EX-32.1 - EXHIBIT 32.1 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC.crl12262015-ex321.htm
EX-21.1 - EXHIBIT 21.1 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC.crl12262015-ex211.htm
EX-31.1 - EXHIBIT 31.1 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC.crl12262015-ex311.htm
EX-31.2 - EXHIBIT 31.2 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC.crl12262015-ex312.htm
EX-10.8 - EXHIBIT 10.8 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC.crl12262015-ex108.htm
EX-10.18 - EXHIBIT 10.18 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC.crl12262015-ex1018.htm
EX-10.17 - EXHIBIT 10.17 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC.crl12262015-ex1017.htm
EX-10.16 - EXHIBIT 10.16 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC.crl12262015-ex1016.htm
10-K - 10-K - CHARLES RIVER LABORATORIES INTERNATIONAL, INC.crl1226201510k.htm

Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-3ASR (No.  333-205954) and Forms S-8 (No. 333-190292, No. 333-174971, No. 333-161024, No. 333-144177, No. 333-124853, No. 333-105803, No. 333-61336 and No. 333-47768) of Charles River Laboratories International, Inc. of our report dated February 12, 2016 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP

Boston, Massachusetts
February 12, 2016